Eli Lilly cuts price of weight-loss drug Zepbound to take on copycats
Eli Lilly and Company cut the prices of its weight-loss drug Zepbound, available in single-dose vials, in a bid to end compounding companies from.
Drugs
Health
Pharma
Uncategorized
New obesity, diabetic cures may emerge as scientists unveil brain atlas
Scientists have created an atlas of individual cells within the human brain region of the hypothalamus and identified new genes linked to obesity.
Health
Pharma
Research
Beyond body mass index, experts hone in on new definition of obesity
Obesity, as defined by the standard body mass index, is erroneous, and the condition should be split into two — pre-clinical and clinical,.
Drugs
Health
Medical
Novo Nordisk, Valo expand pact to include obesity, diabetic drugs
Novo Nordisk A/S, a Danish pharmaceutical company, has expanded its agreement with US-based Valo Health Inc., almost to double the number of drugs.
Uncategorized
Eli Lilly to expand US facility as demand soars for diabetes, obesity medicines
Eli Lilly and Company will invest $3 billion in the US to expand its manufacturing facility to meet a rise in demand for.
Health
Lilly’s trial results for treating obesity and pre-diabetes are promising
HQ Team November 15, 2024: Eli Lilly’s Phase III trial has yielded positive results from the SURMOUNT-1 study of tirzepatide (Zepbound and Mounjaro) for.
Drugs
Health
Pharma
Global diabetic population rose fourfold to 828 million in 2022
The global diabetic population has risen fourfold to 828 million during the last three decades, with more than a quarter living in India,.
Drugs
Health
Pharma
Novo Nordisk’s weight loss drug reduces liver scarring in end-stage trial
Danish multinational pharmaceutical company Novo Nordisk’s end-stage trial in patients with fatty liver disease saw reduced liver scarring (fibrosis) and its resolution without.
Drugs
Health
Medical
Maternal eating disorder linked to increased psychiatric risks in offspring
Bharti Jayshankar October 24, 2024: In a Finnish population-based cohort study, researchers have found that mothers with a history of eating disorders or.
Drugs
Health
Pharma
Novo’s Wegovy gets EMA nod to treat heart failure in obese people
Denmark’s Novo Nordisk got the backing of the European Medicines Agency for its Wegovy drug to reduce heart failure in obese people.